Literature DB >> 3971304

Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system.

J C Rosenberg, H Budev, R C Edwards, S Singal, Z Steiger, A S Sundareson.   

Abstract

Based on a retrospective review of nine patients with adenocarcinoma in a Barrett's esophagus and the reports of similar cases in the literature, a staging system for this malignancy was devised. A progression of changes could be identified that corresponded to the stages. These changes consisted of dysplasia progressing to carcinoma in situ and invasive malignancy with metastases. Stage III disease carried the same grim prognosis as a similar stage of squamous cell carcinoma of the esophagus. Earlier stages of adenocarcinoma of the esophagus appeared to have a better prognosis. White men with symptoms of reflux esophagitis, esophageal strictures, and/or hiatal hernias who have Barrett's esophagus extending proximal to the distal 10 cm of the esophagus appear to have a propensity to develop adenocarcinoma of the esophagus. Consideration should be given to antireflux surgery and close follow-up by periodic esophagoscopy and biopsy of the esophagus in these patients. If neoplasia is found, the thoracic esophagus should be totally removed with the stomach or left colon anastomosed to the cervical esophagus. Because of the poor prognosis of Stage III disease, postoperative chemotherapy should be considered.

Entities:  

Mesh:

Year:  1985        PMID: 3971304     DOI: 10.1002/1097-0142(19850315)55:6<1353::aid-cncr2820550632>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Barrett's oesophagus.

Authors:  R M Navaratnam; M C Winslet
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

2.  Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.

Authors:  Ewa E Hennig; Michal Mikula; Janina Orlowska; Dorota Jarosz; Andrzej Bielasik; Jaroslaw Regula; Jerzy Ostrowski
Journal:  J Mol Med (Berl)       Date:  2007-10-19       Impact factor: 4.599

3.  Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.

Authors:  Jerzy Ostrowski; Michal Mikula; Jakub Karczmarski; Tymon Rubel; Lucjan S Wyrwicz; Piotr Bragoszewski; Pawel Gaj; Michal Dadlez; Eugeniusz Butruk; Jaroslaw Regula
Journal:  J Mol Med (Berl)       Date:  2007-03-30       Impact factor: 4.599

4.  Adenocarcinomas arising in tongues or short segments of Barrett's esophagus.

Authors:  T G Schnell; S J Sontag; G Chejfec
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

5.  Carcinogenesis of Barrett's esophagus: a review of the clinical literature.

Authors:  Jiro Watari; Tadayuki Oshima; Hirokazu Fukui; Toshihiko Tomita; Hiroto Miwa
Journal:  Clin J Gastroenterol       Date:  2013-08-14

6.  Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis.

Authors:  A Csendes; F Maluenda; I Braghetto; P Csendes; A Henriquez; M S Quesada
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

Review 7.  The neoplastic potential of columnar-lined (Barrett's) esophagus.

Authors:  G N Tytgat; W Hameeteman
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

8.  Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma.

Authors:  Kamal E Bani-Hani; Bayan K Bani-Hani; Iain G Martin
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

9.  Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma.

Authors:  G Heidl; P Langhans; W Mellin; H Bünte; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  [Barrett esophagus as a precancerous condition].

Authors:  J R Siewert; A H Hölscher
Journal:  Langenbecks Arch Chir       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.